FIL Ltd cut its holdings in Humana Inc. (NYSE:HUM - Free Report) by 37.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 79,958 shares of the insurance provider's stock after selling 46,876 shares during the period. FIL Ltd owned approximately 0.07% of Humana worth $20,286,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also recently added to or reduced their stakes in HUM. Shelton Capital Management raised its holdings in Humana by 148.2% during the fourth quarter. Shelton Capital Management now owns 11,892 shares of the insurance provider's stock worth $3,017,000 after buying an additional 7,100 shares during the last quarter. Invesco Ltd. increased its holdings in Humana by 29.8% during the fourth quarter. Invesco Ltd. now owns 2,397,808 shares of the insurance provider's stock worth $608,348,000 after buying an additional 550,692 shares during the last quarter. Federated Hermes Inc. lifted its stake in Humana by 231.9% in the fourth quarter. Federated Hermes Inc. now owns 78,357 shares of the insurance provider's stock valued at $19,880,000 after purchasing an additional 54,751 shares during the last quarter. MIG Capital LLC bought a new position in Humana during the fourth quarter valued at $37,844,000. Finally, Columbus Hill Capital Management L.P. increased its position in Humana by 36.5% in the fourth quarter. Columbus Hill Capital Management L.P. now owns 112,622 shares of the insurance provider's stock worth $28,573,000 after buying an additional 30,132 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several equities research analysts recently weighed in on HUM shares. StockNews.com raised Humana from a "hold" rating to a "buy" rating in a report on Monday, April 7th. Truist Financial boosted their price target on shares of Humana from $290.00 to $325.00 and gave the company a "hold" rating in a research report on Friday, April 11th. Robert W. Baird raised their price objective on shares of Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a report on Tuesday. Mizuho lifted their price objective on shares of Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Finally, JPMorgan Chase & Co. cut their price target on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a report on Tuesday, February 18th. Seventeen research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $284.90.
View Our Latest Stock Report on Humana
Humana Stock Down 0.5 %
NYSE HUM traded down $1.30 during trading on Wednesday, hitting $285.48. The company's stock had a trading volume of 1,318,445 shares, compared to its average volume of 1,749,400. The company has a market cap of $34.46 billion, a PE ratio of 28.69, a P/E/G ratio of 2.05 and a beta of 0.62. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The business's 50 day simple moving average is $265.57 and its 200-day simple moving average is $270.22.
Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, equities analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.
Humana Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.24%. Humana's dividend payout ratio (DPR) is presently 35.58%.
About Humana
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Further Reading

Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.